These findings indicate that elevated serum Tyr levels are associated with adverse clinical outcomes, including obesity (higher BMI), diabetes mellitus (higher FPG and HbA1c levels), dyslipidemia (higher TG levels and lower HDL-C levels), and abnormalities in liver function (higher ALT and AST levels). This evidence concerns the gene GPT and Obesity.